Natalino Simioni

803 total citations
24 papers, 463 citations indexed

About

Natalino Simioni is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Natalino Simioni has authored 24 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Natalino Simioni's work include Diabetes Treatment and Management (14 papers), Metabolism, Diabetes, and Cancer (12 papers) and Diabetes Management and Research (10 papers). Natalino Simioni is often cited by papers focused on Diabetes Treatment and Management (14 papers), Metabolism, Diabetes, and Cancer (12 papers) and Diabetes Management and Research (10 papers). Natalino Simioni collaborates with scholars based in Italy and Belgium. Natalino Simioni's co-authors include M. E. Girelli, B Busnardo, Davide Nacamulli, Vera Frison, Angelo Avogaro, Gian Paolo Fadini, Annunziata Lapolla, M. Dambrosio, Agostino Paccagnella and Mauro Rigato and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Atherosclerosis.

In The Last Decade

Natalino Simioni

22 papers receiving 444 citations

Peers

Natalino Simioni
Sarah Theurer Germany
Jesús Barreiro Spain
Eduardo Larrañaga Spain
Yoshinori Ozeki Japan
O Weiss Israel
Anna Popławska‐Kita Poland
Steve Bain United Kingdom
Osamu Funae Japan
Corinne A. Schuyler United States
Sarah Theurer Germany
Natalino Simioni
Citations per year, relative to Natalino Simioni Natalino Simioni (= 1×) peers Sarah Theurer

Countries citing papers authored by Natalino Simioni

Since Specialization
Citations

This map shows the geographic impact of Natalino Simioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalino Simioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalino Simioni more than expected).

Fields of papers citing papers by Natalino Simioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalino Simioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalino Simioni. The network helps show where Natalino Simioni may publish in the future.

Co-authorship network of co-authors of Natalino Simioni

This figure shows the co-authorship network connecting the top 25 collaborators of Natalino Simioni. A scholar is included among the top collaborators of Natalino Simioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalino Simioni. Natalino Simioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonora, Benedetta Maria, Mauro Rigato, Vera Frison, et al.. (2021). Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine care. Diabetes Research and Clinical Practice. 173. 108686–108686. 8 indexed citations
2.
Morieri, Mario Luca, Giovanni Targher, Annunziata Lapolla, et al.. (2021). Changes in markers of hepatic steatosis and fibrosis in patients with type 2 diabetes during treatment with glucagon-like peptide-1 receptor agonists. A multicenter retrospective longitudinal study. Nutrition Metabolism and Cardiovascular Diseases. 31(12). 3474–3483. 9 indexed citations
3.
Morieri, Mario Luca, Mauro Rigato, Vera Frison, et al.. (2020). Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies. Metabolism. 106. 154190–154190. 25 indexed citations
4.
Zenari, Luciano, Andrea Da Porto, Lorena De Moliner, et al.. (2020). Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira). Diabetes Therapy. 12(1). 197–209. 15 indexed citations
5.
Fadini, Gian Paolo, Vera Frison, Mauro Rigato, et al.. (2019). Trend 2010–2018 in the clinical use of GLP-1 receptor agonists for the treatment of type 2 diabetes in routine clinical practice: an observational study from Northeast Italy. Acta Diabetologica. 57(3). 367–375. 21 indexed citations
6.
Morieri, Mario Luca, Mauro Rigato, Vera Frison, et al.. (2019). Fixed versus flexible combination of GLP‐1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study. Diabetes Obesity and Metabolism. 21(11). 2542–2552. 19 indexed citations
7.
Simioni, Natalino, Cesare Berra, Massimo Boemi, et al.. (2018). Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting. Acta Diabetologica. 55(6). 557–568. 18 indexed citations
8.
Frison, Vera, Natalino Simioni, Sara Balzano, et al.. (2018). Clinical Impact of 5 Years of Liraglutide Treatment on Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus in a Real-Life Setting in Italy: An Observational Study. Diabetes Therapy. 9(6). 2201–2208. 9 indexed citations
9.
Fadini, Gian Paolo, Benedetta Maria Bonora, Annunziata Lapolla, et al.. (2018). Comparative effectiveness of exenatide once‐weekly versus liraglutide in routine clinical practice: A retrospective multicentre study and meta‐analysis of observational studies. Diabetes Obesity and Metabolism. 21(5). 1255–1260. 10 indexed citations
10.
Simioni, Natalino, Alessio Filippi, Marco Scardapane, et al.. (2017). Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study. Diabetes Therapy. 8(4). 941–946. 7 indexed citations
11.
Lapolla, Annunziata, Cesare Berra, Massimo Boemi, et al.. (2017). Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study. Advances in Therapy. 35(2). 243–253. 22 indexed citations
12.
Simioni, Natalino. (2016). Inpatient hyperglycemia management: the opportunities of a new basal insulin. Italian Journal of Medicine. 10(2). 103–103. 3 indexed citations
13.
Piva, Anna, Alessio Filippi, & Natalino Simioni. (2014). A dangerous mixture. Italian Journal of Medicine. 8(4). 262–262.
14.
Fadini, Gian Paolo, et al.. (2013). Independent glucose and weight-reducing effects of Liraglutide in a real-world population of type 2 diabetic outpatients. Acta Diabetologica. 50(6). 943–949. 42 indexed citations
15.
Vestra, Michele Dalla, Lolita Sasset, Giulia Chiesa, et al.. (2008). Acute septic arthritis: remember gonorrhea. Rheumatology International. 29(1). 81–85. 17 indexed citations
16.
Vestra, Michele Dalla, et al.. (2008). Renal effects of dual renin–angiotensin–aldosterone system blockade in patients with diabetic nephropathy. International Urology and Nephrology. 41(1). 119–126. 7 indexed citations
17.
Besi, Pietro De, B Busnardo, M. E. Girelli, et al.. (1991). Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. Journal of Endocrinological Investigation. 14(6). 475–480. 72 indexed citations
18.
19.
Simioni, Natalino, et al.. (1984). Parathyroid Hormone and Calcitonin in Thyrotoxicosis. Hormone and Metabolic Research. 16(7). 384–385. 3 indexed citations
20.
Busnardo, B, et al.. (1984). Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma. Cancer. 53(2). 278–285. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Theurer Breakdown of academic impact, for papers by Jesús Barreiro Breakdown of academic impact, for papers by Eduardo Larrañaga Breakdown of academic impact, for papers by Yoshinori Ozeki Breakdown of academic impact, for papers by O Weiss Breakdown of academic impact, for papers by Anna Popławska‐Kita Breakdown of academic impact, for papers by Steve Bain Breakdown of academic impact, for papers by Osamu Funae Breakdown of academic impact, for papers by Corinne A. Schuyler
Rankless by CCL
2026